LUCD
Lucid Diagnostics Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.94
−1.23%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 18.12x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 16.42x
- Price / sales
- 32.95x
- Price / cash flow
- -3.83x
Enterprise value
- Enterprise value
- $170.9M
- EV / sales
- 31.39x
- EV / EBITDA
- -3.33x
- EV / EBIT
- -3.37x
- Market cap
- $179.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026